Qyuns Therapeutics Co., Ltd. reported that, as of 28 February 2026, its authorized share capital remained at 227.07 million shares with a par value of RMB 1, totaling RMB 227.07 million. Issued shares (excluding treasury shares) decreased from 224.87 million to 224.57 million, while treasury shares increased from 2.20 million to 2.50 million. Overall, the total number of shares remained 227.07 million.

According to the announcement, 307,000 shares were repurchased on 2, 3, 4, and 6 February 2026 at prices ranging from HKD 20.12 to HKD 20.24. These repurchased shares were held as treasury shares, and the applicable public float requirement continued to be met. No other movements in issued shares, convertible securities, or share options were recorded for the period.